001     186051
005     20240625095118.0
024 7 _ |a 10.1021/ct500402e
|2 doi
024 7 _ |a 1549-9618
|2 ISSN
024 7 _ |a 1549-9626
|2 ISSN
024 7 _ |a WOS:000340351200068
|2 WOS
024 7 _ |a altmetric:2500377
|2 altmetric
024 7 _ |a pmid:26588321
|2 pmid
037 _ _ |a FZJ-2015-00152
082 _ _ |a 540
100 1 _ |0 P:(DE-HGF)0
|a Nguyen, Trung Hai
|b 0
245 _ _ |a Molecular Recognition of Platinated DNA from Chromosomal HMGB1
260 _ _ |a Washington, DC
|b American Chemical Society (ACS)
|c 2014
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1435742680_1776
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |2 DRIVER
|a article
520 _ _ |a Cisplatin cures testicular and ovarian cancers with unprecedented potency. It induces its beneficial activity by covalently binding to DNA. Repair enzymes, which remove the platinated lesions from DNA, cause drug resistance. Chromosomal High Mobility Group Box proteins (HMGB) may interfere with this process by binding to platinated DNA. Using 8 μs multiple-walker well-tempered metadynamics simulations, here, we investigated the structural and the energetic determinants of one of the HMGB proteins (HMGB1A) in complex with the platinated oligonucleotide [Pt(NH3)2]2+-d(CCUCTCTG*G*ACCTTCC)-d(GGAGAGACCTGGAAGG) (*G are platinated guanines), for which experimental structural information is available. The calculated affinity is in good agreement with experiment. The process is predicted to be enthalpy-driven, as found for other protein/DNA complexes. The Lys7 residue, whose side-chain was not resolved in the X-ray structure, is found to interact with the C4 5′-phosphate and this interaction emerges as a key facet for the molecular recognition process. In addition, our calculations provide a molecular basis for the experimentally measured decreased affinity of HMGB1A for platinated DNA, as a consequence of Cys22-Cys44 S–S bridge formation (such an oxidation cannot take place in some members of this protein family present in the testis, where the drug is particularly effective). This decrease is likely to be caused by a small yet significant rearrangement of helices H1 and H2 with consequent alteration of the Phe37 juxtaposition.
536 _ _ |0 G:(DE-HGF)POF2-411
|a 411 - Computational Science and Mathematical Methods (POF2-411)
|c POF2-411
|f POF II
|x 0
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |0 P:(DE-Juel1)145921
|a Rossetti, Giulia
|b 1
|e Corresponding Author
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Arnesano, Fabio
|b 2
700 1 _ |0 P:(DE-Juel1)146009
|a Ippoliti, Emiliano
|b 3
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Natile, Giovanni
|b 4
700 1 _ |0 P:(DE-Juel1)145614
|a Carloni, Paolo
|b 5
|u fzj
773 _ _ |0 PERI:(DE-600)2166976-4
|a 10.1021/ct500402e
|g Vol. 10, no. 8, p. 3578 - 3584
|n 8
|p 3578 - 3584
|t Journal of chemical theory and computation
|v 10
|x 1549-9626
|y 2014
856 4 _ |u https://juser.fz-juelich.de/record/186051/files/FZJ-2015-00152.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:186051
|p VDB
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)145921
|a Forschungszentrum Jülich GmbH
|b 1
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)146009
|a Forschungszentrum Jülich GmbH
|b 3
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)145614
|a Forschungszentrum Jülich GmbH
|b 5
|k FZJ
913 2 _ |0 G:(DE-HGF)POF3-511
|1 G:(DE-HGF)POF3-510
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l Supercomputing & Big Data
|v Computational Science and Mathematical Methods
|x 0
913 2 _ |0 G:(DE-HGF)POF3-574
|1 G:(DE-HGF)POF3-570
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|v Theory, modelling and simulation
|x 1
913 1 _ |0 G:(DE-HGF)POF2-411
|1 G:(DE-HGF)POF2-410
|2 G:(DE-HGF)POF2-400
|a DE-HGF
|b Schlüsseltechnologien
|l Supercomputing
|v Computational Science and Mathematical Methods
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
914 1 _ |y 2014
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)1150
|2 StatID
|a DBCoverage
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
920 1 _ |0 I:(DE-Juel1)JSC-20090406
|k JSC
|l Jülich Supercomputing Center
|x 0
920 1 _ |0 I:(DE-Juel1)IAS-5-20120330
|k IAS-5
|l Computational Biomedicine
|x 1
920 1 _ |0 I:(DE-Juel1)INM-9-20140121
|k INM-9
|l Computational Biomedicine
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)JSC-20090406
980 _ _ |a I:(DE-Juel1)IAS-5-20120330
980 _ _ |a I:(DE-Juel1)INM-9-20140121
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IAS-5-20120330
981 _ _ |a I:(DE-Juel1)INM-9-20140121


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21